Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 2016, Article ID 6873689, 5 pages
http://dx.doi.org/10.1155/2016/6873689
Research Article

Acinetobacter Infections among Adult Patients in Qatar: A 2-Year Hospital-Based Study

1Infectious Diseases Division, Department of Medicine, Al Khor Hospital, Al Khor, Qatar
2Department of Medicine, Hamad General Hospital, Doha, Qatar
3Infectious Diseases Division, Department of Medicine, Hamad General Hospital, Doha, Qatar
4Department of Medicine, Al Khor Hospital, Al Khor, Qatar

Received 21 February 2016; Revised 23 May 2016; Accepted 2 June 2016

Academic Editor: Giordano Dicuonzo

Copyright © 2016 Musaed Saad Al Samawi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Kock, A. N. Bellomo, N. Storm, and M. M. Ehlers, “Prevalence of carbapenem resistance genes in Acinetobacter baumannii isolated from clinical specimens obtained from an academic hospital in South Africa,” Southern African Journal of Infectious Diseases, vol. 28, pp. 28–32, 2013. View at Google Scholar
  2. M. Wadl, K. Heckenbach, I. Noll et al., “Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four german university hospitals, 2002–2006,” Infection, vol. 38, no. 1, pp. 47–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. W.-S. Leung, C.-M. Chu, K.-Y. Tsang, F.-H. Lo, K.-F. Lo, and P.-L. Ho, “Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome,” Chest, vol. 129, no. 1, pp. 102–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. P. E. Fournier and H. Richet, “The epidemiology and control of Acinetobacter baumannii in health care facilities,” Clinical Infectious Diseases, vol. 42, no. 5, pp. 692–699, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Y. Khan, M. Abukhattab, and K. Baager, “Nosocomial postneurosurgical acinetobacter baumannii meningitis: a retrospective study of six cases admitted to hamad general hospital, Qatar,” Journal of Hospital Infection, vol. 80, no. 2, pp. 176–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Y. Khan, S. S. Elshafie, M. Almaslamani et al., “Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study,” Travel Medicine and Infectious Disease, vol. 8, no. 6, pp. 377–387, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C.-I. Kang, S.-H. Kim, B. P. Wan et al., “Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 2, pp. 760–766, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. N. B. A. Ntusi, M. Badri, H. Khalfey et al., “ICU-associated Acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting,” PLoS ONE, vol. 7, no. 12, Article ID e52452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. C. Bone, R. A. Balk, F. B. Cerra et al., “Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine,” Chest, vol. 136, no. 5, p. e28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Falagas, P. K. Koletsi, and I. A. Bliziotis, “The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa,” Journal of Medical Microbiology, vol. 55, no. 12, pp. 1619–1629, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Clinical and Laboratory Standards Institute, “Performance standards for antimicrobial susceptibility testing; 24th informational supplement,” CLSI M100-S21, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2011. View at Google Scholar
  12. G. Rivera, J. Bulnes, C. Castillo, M. C. Ajenjo, P. García, and J. Labarca, “Extensively drug-resistant Acinetobacter baumannii isolated in a university hospital: role of inter-hospital transmission,” Journal of Infection in Developing Countries, vol. 10, no. 1, pp. 96–99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. L. L. Maragakis and T. M. Perl, “Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options,” Clinical Infectious Diseases, vol. 46, no. 8, pp. 1254–1263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Rodríguez-Baño, J. M. Cisneros, F. Fernández-Cuenca et al., “Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals,” Infection Control and Hospital Epidemiology, vol. 25, no. 10, pp. 819–824, 2004. View at Publisher · View at Google Scholar
  15. N. Jaggi, P. Sissodia, and L. Sharma, “Acinetobacter baumannii isolates in a tertiary care hospital: antimicrobial resistance and clinical significance,” Journal of Microbiology and Infectious Diseases, vol. 2, pp. 57–63, 2012. View at Google Scholar
  16. S. Begum, F. Hasan, S. Hussain, and A. A. Shah, “Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from tertiary care hospital in Islamabad, Pakistan,” Pakistan Journal of Medical Sciences, vol. 29, no. 5, pp. 1253–1258, 2013. View at Google Scholar · View at Scopus
  17. M. Chaudhary and A. Payasi, “Incidence, prevalence and control of multidrug resistant (MDR) carbapenemase producing Acinetobacter baumanii in Indian intensive care units,” Journal of Pharmacy Research, vol. 7, no. 2, pp. 175–180, 2013. View at Publisher · View at Google Scholar
  18. N. Sinha, J. Agarwal, S. Srivastava, and M. Singh, “Analysis of carbapenem-resistant Acinetobacter from a tertiary care setting in North India,” Indian Journal of Medical Microbiology, vol. 31, no. 1, pp. 60–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Mahajan, S. Sheemar, S. Chopra, J. Kaur, D. Chowdhary, and S. K. Makhija, “Carbapenem resistance and phenotypic detection of carbapenemases in clinical isolates of acinetobacter baumannii,” Indian Journal of Medical Sciences, vol. 65, no. 1, pp. 18–25, 2010. View at Google Scholar · View at Scopus
  20. A. Versporten, S. Coenen, N. Adriaenssens et al., “European surveillance of antimicrobial consumption (ESAC): outpatient cephalosporin use in Europe (1997–2009),” Journal of Antimicrobial Chemotherapy, vol. 67, no. 2, Article ID dkr530, pp. 518–518, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Gur, V. Korten, S. Unal, L. M. Deshpande, and M. Castanheira, “Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites,” Journal of Medical Microbiology, vol. 57, no. 12, pp. 1529–1532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ziglam, O. Elahmer, S. Amri et al., “Antimicrobial resistance patterns among Acinetobacter baumannii isolated from burn intensive care unit in Tripoli, Libya,” International Arabic Journal of Antimicrobial Agents, vol. 2, no. 3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Moradi, F. B. Hashemi, and A. Bahador, “Antibiotic resistance of Acinetobacter baumannii in Iran: a systemic review of the published literature,” Osong Public Health and Research Perspectives, vol. 6, no. 2, pp. 79–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Aydemir, G. Celebi, N. Piskin et al., “Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital,” Japanese Journal of Infectious Diseases, vol. 65, no. 1, pp. 66–71, 2012. View at Google Scholar · View at Scopus
  25. L. Poirel and P. Nordmann, “Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology,” Clinical Microbiology and Infection, vol. 12, no. 9, pp. 826–836, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. U. J. Kim, H. K. Kim, J. H. An, S. K. Cho, K. Park, and H. Jang, “Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections,” Chonnam Medical Journal, vol. 50, no. 2, pp. 37–44, 2014. View at Publisher · View at Google Scholar
  27. A. Ulu-Kilic, S. Ahmed, E. Alp, and M. Doğanay, “Challenge of intensive care unit-acquired infections and Acinetobacter baumannii in developing countries,” OA Critical Care, vol. 1, no. 1, 2013. View at Publisher · View at Google Scholar
  28. J. W. Liu, L. S. Wang, Y. J. Cheng et al., “In-vitro activity of tigecycline against clinical isolates of Acinetobacterbaumannii in Taiwan,” International Journal of Antimicrobial Agents, vol. 32, supplement 3, pp. S188–191, 2008. View at Google Scholar
  29. R. Ricciardi, A. M. Ricciardi, and G. Danzi, “In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates,” Infezioni in Medicina, vol. 17, no. 4, pp. 236–239, 2009. View at Google Scholar · View at Scopus
  30. S. Tiengrim, C. Tribuddharat, and V. Thamlikitkul, “In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand,” Journal of the Medical Association of Thailand, vol. 89, supplement 5, pp. S102–S105, 2006. View at Google Scholar · View at Scopus
  31. D. E. Karageorgopoulos, T. Kelesidis, I. Kelesidis, and M. E. Falagas, “Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 1, pp. 45–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. F. E. Ö. Akin, A. Bayram, and I. Balci, “Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant acinetobacter baumannii isolates,” Mikrobiyoloji Bulteni, vol. 44, no. 2, pp. 203–210, 2010. View at Google Scholar · View at Scopus
  33. Y. K. Park, S.-I. Jung, K.-H. Park et al., “Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea,” Diagnostic Microbiology and Infectious Disease, vol. 64, no. 1, pp. 43–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Sinirtaş, H. Akalin, and S. Gedikoǧlu, “Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance,” International Journal of Infectious Diseases, vol. 13, no. 5, pp. e217–e220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. H. Sunenshine, M.-O. Wright, L. L. Maragakis et al., “Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization,” Emerging Infectious Diseases, vol. 13, no. 1, pp. 97–103, 2007. View at Publisher · View at Google Scholar · View at Scopus